![Ironwood Pharmaceuticals, Inc. - Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout Ironwood Pharmaceuticals, Inc. - Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout](http://mms.businesswire.com/media/20161003005125/en/547448/4/ZURAMPIC%28R%29_Product_Shot_FINAL.jpg)
Ironwood Pharmaceuticals, Inc. - Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout
![Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol | Annals of the Rheumatic Diseases Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/75/6/1074/F1.large.jpg)
Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol | Annals of the Rheumatic Diseases
![Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets | Molecular Pharmaceutics Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.6b00497/asset/images/medium/mp-2016-004978_0017.gif)
Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets | Molecular Pharmaceutics
![Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets | Molecular Pharmaceutics Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.6b00497/asset/images/medium/mp-2016-004978_0008.gif)
Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets | Molecular Pharmaceutics
Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males - Document - Gale Academic OneFile
![Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor - Shen - 2019 - Clinical Pharmacology in Drug Development - Wiley Online Library Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor - Shen - 2019 - Clinical Pharmacology in Drug Development - Wiley Online Library](https://accp1.onlinelibrary.wiley.com/cms/asset/8cb568f0-8213-42aa-8735-730b662f8929/cpdd663-fig-0003-m.jpg)
Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor - Shen - 2019 - Clinical Pharmacology in Drug Development - Wiley Online Library
![Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout | Business Wire Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout | Business Wire](https://mms.businesswire.com/media/20170821005414/en/607691/5/200-300_Bottle_FINAL_highres.jpg)
Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout | Business Wire
![Vamani Healthcare on X: "New #Drug_Approvals #Duzallo (allopurinol and lesinurad) #Tablets Visit- https://t.co/E7IQcMfH5C https://t.co/XPTcTgARF3" / X Vamani Healthcare on X: "New #Drug_Approvals #Duzallo (allopurinol and lesinurad) #Tablets Visit- https://t.co/E7IQcMfH5C https://t.co/XPTcTgARF3" / X](https://pbs.twimg.com/media/DL_zRJtUMAAH2Jo.jpg)